Vilazodone Shows Promise in Mitigating Methylphenidate’s Neurological Risks
Professor Heinz Steiner's team found in rats that, unlike fluoxetine, the antidepressant vilazodone does not amplify methylphenidate's effects on gene regulation in the striatum.